Selegiline in Parkinson's disease. [electronic resource]
Producer: 19960227Description: 1583-4 p. digitalISSN:- 0959-8138
- Antiparkinson Agents -- adverse effects
- Clinical Trials as Topic
- Drug Therapy, Combination
- Humans
- Levodopa -- therapeutic use
- Monoamine Oxidase Inhibitors -- adverse effects
- Neuroprotective Agents -- adverse effects
- Parkinson Disease -- drug therapy
- Selegiline -- adverse effects
- Treatment Failure
- United Kingdom
No physical items for this record
Publication Type: Editorial; Comment
There are no comments on this title.
Log in to your account to post a comment.